FDA reverses decision on liquid morphine

May 2009
Hospice Management Advisor;May2009, Vol. 14 Issue 5, p60
The article reports on the amendment made by the U.S. Food and Drug Administration (FDA) on a March 30, 2009 decision over the production and manufacturing of unapproved prescription opioids, including liquid morphine, following concerns raised by hospice and palliative care organizations. It says that liquid morphine is a common medication used for hospice patients with pain that cannot be controlled with other medications. However, it notes that FDA will be ensuring all prescription drugs.


Related Articles

  • Action from FDA results in some hospice drug shortages.  // Hospice Management Advisor;Aug2009, Vol. 14 Issue 8, p85 

    The article focuses on the issues concerning the restrictions made by the U.S. Food and Drug Administration (FDA) over the manufacturing of opioid medications. Due to the restrictions, the hospice industry still are finding shortages of opioid and is scrambling to find alternative pain...

  • Announcements.  // Journal of Palliative Medicine;Jul2009, Vol. 12 Issue 7, p663 

    The article offers news briefs related to palliative care in the U.S. The self-assessment examinations (SAEs) from the Logic Extension Resources LXR Store can be an effective learning tools for nurses. The Food and Drug Administration (FDA) is planning to implement restrictions on prescriptions...

  • WEEK IN WASHINGTON.  // BioWorld Insight;4/19/2010, Vol. 18 Issue 16, p6 

    The article offers news briefs related to the operations of the U.S. Food and Drug Administration (FDA) including its move to warn some drugmakers about misleading materials and the opening FD's public meeting that discusses the Prescription Drug User Fee Act (PDUFA) V renewal process.

  • Morphine sulfate solution receives FDA approval.  // Hospice Management Advisor;Mar2010, Vol. 15 Issue 3, p31 

    The article reports that the morphine sulfate oral solution has been approved by the U.S. Food and Drug Administration (FDA) as pain relief medicine in opioid-tolerant patients. The drug will be available in 100 mg per 5 mL or 20 mg per 1 mL. The oral morphine will be used for moderate to...

  • FDA Notice to Halt Morphine Production Causes Concern.  // Journal of Gerontological Nursing;Jul2009, Vol. 35 Issue 7, p35 

    The article reports that the American Society of Consultant Pharmacists (ASCP) calls for remedial action after the U.S. Food and Drug Administration's (FDA) notice to halt the manufacturing of morphine sulphate 20 mg/mL oral concentrate was disapproved. The ASCP has cited the shortage of...

  • New rules for opioid prescribing.  // Critical Care Alert;Apr2009 Pharmacology, p2 

    The article reports on the restrictions imposed by the Food & Drug Administration (FDA) on the use of opioid drugs in the U.S.

  • Off-label prescribing might get boost from FDA. Edlin, Mari // Managed Healthcare Executive;Apr2008, Vol. 18 Issue 4, p26 

    The article focuses on the new draft guidance that would enable pharmaceutical companies to give physicians journal articles that explain product uses that are not yet approved by the U.S. Food and Drug Administration (FDA). The new guidance would serve as replacement for the FDA Modernization...

  • An Off-Label Update.  // People's Medical Society Newsletter;Jun99, Vol. 18 Issue 3, p1 

    Reports on the United States Food and Drug Administration (FDA) Modernization Act of 1997, which includes provisions that allow off-label uses of prescribed drugs for treatment of diseases other than those specifically indicated. Procedure for FDA approval of a drug; Requirements for the...

  • New rules for opioid prescribing. Elliott, William T. // Infectious Disease Alert;Apr2009 Pharmacology, p2 

    The article reports on the plans of the U.S. Food and Drug Administration (FDA) to issue new restrictions for opioid prescribing in 2009. Under the rules, opioid makers will be required to have a Risk Evaluation and Mitigation Strategy. Opioids included in the rules include fentanyl,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics